KIR2DL2, His & Avi, Human
KIR2DL2, His & Avi, Human

The purity of KIR2DL2, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

KIR2DL2, His & Avi, Human

KIR2DL2, His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.

KIR2DL2, His & Avi, Human

KIR2DL2 (2DL2, formerly NKAT6, designated CD158b) is a 348 amino acid (aa) type I transmembrane glycoprotein that belongs to the human killer cell Ig‑like receptor (KIR) family. KIRs are expressed on human CD56dim NK cells and T cell subsets, and regulate effector functions in the innate immune system.KIR2DL2 is receptor on natural killer (NK) cells for HLA-Cw1, 3, 7, and 8 allotypes. Inhibits the activity of NK cells thus preventing cell lysis.
Z05545
¥48,501.00

Ask us a question
Product Introduction
Species Human
Protein Construction
KIR2DL2 (His22-His245)_x000D_
Accession # P43627		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 27.4 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 45-50 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • KIR2DL2, His & Avi, Human
    • KIR2DL2, His & Avi, Human

    The purity of KIR2DL2, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • KIR2DL2, His & Avi, Human
    • KIR2DL2, His & Avi, Human

    KIR2DL2, His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.


Background
Target Background KIR2DL2 (2DL2, formerly NKAT6, designated CD158b) is a 348 amino acid (aa) type I transmembrane glycoprotein that belongs to the human killer cell Ig‑like receptor (KIR) family. KIRs are expressed on human CD56dim NK cells and T cell subsets, and regulate effector functions in the innate immune system.KIR2DL2 is receptor on natural killer (NK) cells for HLA-Cw1, 3, 7, and 8 allotypes. Inhibits the activity of NK cells thus preventing cell lysis.
Synonyms NKAT-6;p58 NK receptor CL-43;CD158b1;KIR2DL2;CD158B1;NKAT6

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.